118 related articles for article (PubMed ID: 29665527)
1. Discovery of 1,8-acridinedione derivatives as novel GCN5 inhibitors via high throughput screening.
Xiong H; Han J; Wang J; Lu W; Wang C; Chen Y; Fulin Lian ; Zhang N; Liu YC; Zhang C; Ding H; Jiang H; Lu W; Luo C; Zhou B
Eur J Med Chem; 2018 May; 151():740-751. PubMed ID: 29665527
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening.
Zhang R; Wang J; Zhao L; Liu S; Du D; Ding H; Chen S; Yue L; Liu YC; Zhang C; Liu H; Luo C
Eur J Med Chem; 2018 Sep; 157():867-876. PubMed ID: 30145373
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule inhibitors of acetyltransferase p300 identified by high-throughput screening are potent anticancer agents.
Yang H; Pinello CE; Luo J; Li D; Wang Y; Zhao LY; Jahn SC; Saldanha SA; Chase P; Planck J; Geary KR; Ma H; Law BK; Roush WR; Hodder P; Liao D
Mol Cancer Ther; 2013 May; 12(5):610-20. PubMed ID: 23625935
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of histone acetyltransferase GCN5 extends lifespan in both yeast and human cell lines.
Huang B; Zhong D; Zhu J; An Y; Gao M; Zhu S; Dang W; Wang X; Yang B; Xie Z
Aging Cell; 2020 Apr; 19(4):e13129. PubMed ID: 32157780
[TBL] [Abstract][Full Text] [Related]
5. Current development of CBP/p300 inhibitors in the last decade.
He ZX; Wei BF; Zhang X; Gong YP; Ma LY; Zhao W
Eur J Med Chem; 2021 Jan; 209():112861. PubMed ID: 33045661
[TBL] [Abstract][Full Text] [Related]
6. Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.
Lu W; Xiong H; Chen Y; Wang C; Zhang H; Xu P; Han J; Xiao S; Ding H; Chen Z; Lu T; Wang J; Zhang Y; Yue L; Liu YC; Zhang C; Yang Y; Jiang H; Chen K; Zhou B; Luo C
Bioorg Med Chem; 2018 Nov; 26(20):5397-5407. PubMed ID: 30297119
[TBL] [Abstract][Full Text] [Related]
7. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
Bowers EM; Yan G; Mukherjee C; Orry A; Wang L; Holbert MA; Crump NT; Hazzalin CA; Liszczak G; Yuan H; Larocca C; Saldanha SA; Abagyan R; Sun Y; Meyers DJ; Marmorstein R; Mahadevan LC; Alani RM; Cole PA
Chem Biol; 2010 May; 17(5):471-82. PubMed ID: 20534345
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening.
Zhang FC; Sun ZY; Liao LP; Zuo Y; Zhang D; Wang J; Chen YT; Xiao SH; Jiang H; Lu T; Xu P; Yue LY; Du DH; Zhang H; Liu CP; Luo C
Acta Pharmacol Sin; 2020 Feb; 41(2):286-292. PubMed ID: 31253937
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties.
Mai A; Rotili D; Tarantino D; Ornaghi P; Tosi F; Vicidomini C; Sbardella G; Nebbioso A; Miceli M; Altucci L; Filetici P
J Med Chem; 2006 Nov; 49(23):6897-907. PubMed ID: 17154519
[TBL] [Abstract][Full Text] [Related]
10. A small molecule inhibitor of fungal histone acetyltransferase Rtt109.
Lopes da Rosa J; Bajaj V; Spoonamore J; Kaufman PD
Bioorg Med Chem Lett; 2013 May; 23(10):2853-9. PubMed ID: 23587423
[TBL] [Abstract][Full Text] [Related]
11. Unravelling novel congeners from acetyllysine mimicking ligand targeting a lysine acetyltransferase PCAF bromodomain.
Suryanarayanan V; Singh SK
J Biomol Struct Dyn; 2018 Dec; 36(16):4303-4319. PubMed ID: 29228881
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors.
Liu R; Zhang Z; Yang H; Zhou K; Geng M; Zhou W; Zhang M; Huang X; Li Y
Eur J Med Chem; 2019 Oct; 180():171-190. PubMed ID: 31306905
[TBL] [Abstract][Full Text] [Related]
13. Gcn5 Modulates the Cellular Response to Oxidative Stress and Histone Deacetylase Inhibition.
Gaupel AC; Begley TJ; Tenniswood M
J Cell Biochem; 2015 Sep; 116(9):1982-92. PubMed ID: 25755069
[TBL] [Abstract][Full Text] [Related]
14. Small molecule inhibitors of histone acetyltransferase Tip60.
Wu J; Wang J; Li M; Yang Y; Wang B; Zheng YG
Bioorg Chem; 2011 Feb; 39(1):53-8. PubMed ID: 21186043
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of GCN5 in human diseases and its therapeutic potential.
Xiao HT; Jin J; Zheng ZG
Biomed Pharmacother; 2023 Sep; 165():114835. PubMed ID: 37352700
[TBL] [Abstract][Full Text] [Related]
16. Che1/AATF interacts with subunits of the histone acetyltransferase core module of SAGA complexes.
Caliskan G; Baris IC; Ayaydin F; Dobson MJ; Senarisoy M; Boros IM; Topcu Z; Zencir S
PLoS One; 2017; 12(12):e0189193. PubMed ID: 29232376
[TBL] [Abstract][Full Text] [Related]
17. Complex functions of Gcn5 and Pcaf in development and disease.
Koutelou E; Farria AT; Dent SYR
Biochim Biophys Acta Gene Regul Mech; 2021 Feb; 1864(2):194609. PubMed ID: 32730897
[TBL] [Abstract][Full Text] [Related]
18. Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.
Chaikuad A; Lang S; Brennan PE; Temperini C; Fedorov O; Hollander J; Nachane R; Abell C; Müller S; Siegal G; Knapp S
J Med Chem; 2016 Feb; 59(4):1648-53. PubMed ID: 26731131
[TBL] [Abstract][Full Text] [Related]
19. Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay.
Lu T; Hu JC; Lu WC; Han J; Ding H; Jiang H; Zhang YY; Yue LY; Chen SJ; Jiang HL; Chen KX; Chai HF; Luo C
Acta Pharmacol Sin; 2018 Sep; 39(9):1544-1552. PubMed ID: 29795359
[TBL] [Abstract][Full Text] [Related]
20. Assays for the identification and evaluation of histone acetyltransferase inhibitors.
Wynne Aherne G; Rowlands MG; Stimson L; Workman P
Methods; 2002 Mar; 26(3):245-53. PubMed ID: 12054880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
